baicalin has been researched along with Influenza, Human in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, R; Guo, L; He, Q; Sun, Z; Wang, C; Wang, S; Wei, Z; Yang, W; Zhang, J; Zhang, X | 1 |
| Li, R; Wang, L | 1 |
| Chen, Y; Dou, J; Guo, M; Jin, J; Ma, L; Wang, D; Zhou, C | 1 |
3 other study(ies) available for baicalin and Influenza, Human
| Article | Year |
|---|---|
Baicalin inhibits influenza A (H1N1)-induced pyroptosis of lung alveolar epithelial cells via caspase-3/GSDME pathway.
Topics: Alveolar Epithelial Cells; Animals; Antiviral Agents; Caspase 3; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung; Mice; Pyroptosis | 2023 |
Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Female; Flavonoids; Gene Expression Profiling; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Interferon Type I; Mice; MicroRNAs; Signal Transduction; Transcriptome; Virus Replication | 2019 |
The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity.
Topics: Administration, Intravenous; Animals; Antiviral Agents; CHO Cells; Cricetulus; Disease Models, Animal; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Flavonoids; Humans; Influenza A virus; Influenza, Human; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Inbred ICR; Neuraminidase; Oseltamivir; Scutellaria; Viral Proteins; Virus Replication | 2018 |